Drugs {puromycin} can block protein synthesis and prevent memory consolidation.
Strychnos amine {strychnine} can reduce glycine binding but not affect glycine receptors. In very low doses, strychnine improves short-term memory and transfer to long-term memory. It is rat poison and can cause convulsions by sensitizing synapses.
Drugs {volado} can affect mushroom bodies, which learn to avoid smells associated with shocks.
Acetylcholine {acetylcholine, receptor} can bind to nicotinic receptors and to receptors {muscarinic receptor} that bind muscarine. Nicotine and muscarine are cholinergic agonists.
Donepezil, galantamine, phenserine, and rivastigmine {acetylcholinesterase-inhibiting drug} {ACh-inhibiting} inhibit acetylcholinesterase, prolonging acetylcholine activity, as in Alzheimer's patients.
Physostigmine {cholinergic agonist} competes for acetylcholine receptor and can improve memory. Pilocarpine cholinergic agonist is for Sjogren's syndrome.
Atropine and Cogentin {cholinergic antagonist} {anticholinergic drug} bind to nicotinic and muscarinic receptors and prevent acetylcholine binding.
Alkaloid cholinergic antagonist {scopolamine}, related to Solanaceae family, depresses memory ability and causes amnesia.
Drugs {anti-cholinesterase} can block cholinesterase and so aid memory.
Thorn-apple drugs {hyoscine, drug} can bind to acetylcholine receptors and affect long-term memory recall.
4-Medicine-Drug-Kinds-Cognition
Outline of Knowledge Database Home Page
Description of Outline of Knowledge Database
Date Modified: 2022.0225